Mucin-1: a promising pan-cancer therapeutic target by Udhayvir Singh Grewal, Razelle Kurzrock

Get full text

Patient rights in precision oncology: right treatment, right time, right dose, right order, right place by Elena Fountzilas, Apostolia-Maria Tsimberidou, Razelle Kurzrock

Get full text

OncoAID: an open access targeted anti-cancer drugs database by Ohad Landau, Shai Magidi, Catherine Bresson, Fanny Wunder, Razelle Kurzrock, Razelle Kurzrock, Wafik S. El-Deiry, Wafik S. El-Deiry, Kartheeswaran Thangathurai, Eitan Rubin

Get full text

Toll-like receptor 3: a double-edged sword by Marvin L Hsieh, Daisuke Nishizaki, Jacob J Adashek, Shumei Kato, Razelle Kurzrock

Get full text

ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy by Razelle Kurzrock, Ryosuke Okamura, Shumei Kato, Suzanna Lee, Rebecca E Jimenez, Jason K Sicklick

Get full text

Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab by Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü, Şevval Nur Bilgiç, Nalan Akgül Babacan, Onur Tutar, Razelle Kurzrock, Mutlu Demiray

Get full text

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab by Razelle Kurzrock, Eytan Ruppin, Raanan Berger, Gal Dinstag, Omer Tirosh, Eyal Schiff, David Kleiner, Kenneth D Aldape, Tuvik Beker

Get full text

ICOS and ICOS ligand: expression patterns and outcomes in oncology patients by Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, Donald A. Barkauskas, Sarabjot Pabla, Mary K. Nesline, Jeffrey M. Conroy, Aung Naing, Razelle Kurzrock

Get full text

4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists by Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K. Nesline, Sarabjot Pabla, Jeffrey M. Conroy, Paul DePietro, Heidi Ko, Jason K. Sicklick, Razelle Kurzrock

Get full text

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection by Daisuke Nishizaki, Razelle Kurzrock, Jacob J. Adashek, Ki Hwan Kim, Hyo Jeong Lim, Mina Nikanjam, Ramez N. Eskander, Paul T. Fanta, Ryosuke Okamura, Suzanna Lee, Jason K. Sicklick, Scott M. Lippman, Shumei Kato

Get full text

Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort by Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Benjamin Tan, Megan Othus, Christine McLeod, Charles Blanke, Helen X Chen, Sandip P Patel, Gabby Lopez, Tridu Huynh, Timothy Kuzel, Christopher W Ryan

Get full text

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the... by Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z. Win, Tanya Pejovic, Sajeve S. Thomas, William R. Robinson III, Hye Sung Kim, Liam Il‐Young Chung, Christine M. McLeod, Helen X. Chen, Elad Sharon, Howard Streicher, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock

Get full text

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort by Ignacio I Wistuba, Jianhua Zhang, Anup Kasi, Hong Chen, Seunghee Kim-Schulze, Holden T Maecker, Elad Sharon, Razelle Kurzrock, Sacha Gnjatic, Young Kwang Chae, Jiexin Zhang, Jianjun Zhang, Sandip Pravin Patel, Cara L Haymaker, Megan Othus, Charles Blanke, Edwin Parra, Gheath Al-Atrash, Caroline Duault, J Jack Lee, Helen X Chen, Edgar Gonzalez-Kozlova, Dzifa Yawa Duose, Luisa Solis Soto, Ganiraju Manyam, Christopher W Ryan, Jillian Fisher, Bhavana Konda, Mark Walshauser, Caddie Laberiano Fernandez, Raja Luthra, Christine M Magner

Get full text